Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Mol Cell Neurosci ; 123: 103792, 2022 12.
Article in English | MEDLINE | ID: mdl-36372157

ABSTRACT

The isolation of synaptoneurosomes (SNs) represents a useful means to study synaptic events. However, the size and density of synapses varies in different regions of the central nervous system (CNS), and this also depends on the experimental species studied, making it difficult to define a generic protocol for SNs preparation. To characterize synaptic failure in the spinal cord (SC) in the Tg-SOD1/G93A mouse model of amyotrophic lateral sclerosis (ALS), we applied a method we originally designed to isolate cortical and hippocampal SNs to SC tissue. Interestingly, we found that the SC SNs were isolated in a different gradient fraction to the cortical/hippocampal SNs. We compared the relative levels of synaptoneurosomal proteins in wild type (WT) animals, with control (Tg-SOD1) or Tg-SOD1/G93A mice at onset and those that were symptomatic using iTRAQ proteomics. The results obtained suggest that an important regulator of local synaptic translation, MNK1 (MAP kinase interacting serine/threonine kinase 1), might well influence the early stages of ALS.


Subject(s)
Amyotrophic Lateral Sclerosis , Mitogen-Activated Protein Kinase 3 , Protein Serine-Threonine Kinases , Animals , Mice , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/metabolism , Disease Models, Animal , Mice, Transgenic , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Proteomics , Spinal Cord/metabolism , Superoxide Dismutase-1/genetics , Superoxide Dismutase-1/metabolism , Mitogen-Activated Protein Kinase 3/genetics , Mitogen-Activated Protein Kinase 3/metabolism
2.
Mol Brain ; 14(1): 84, 2021 05 25.
Article in English | MEDLINE | ID: mdl-34034796

ABSTRACT

Down syndrome (DS) is the most frequent genetic cause of intellectual disability including hippocampal-dependent memory deficits. We have previously reported hippocampal mTOR (mammalian target of rapamycin) hyperactivation, and related plasticity as well as memory deficits in Ts1Cje mice, a DS experimental model. Here we characterize the proteome of hippocampal synaptoneurosomes (SNs) from these mice, and found a predicted alteration of synaptic plasticity pathways, including long term depression (LTD). Accordingly, mGluR-LTD (metabotropic Glutamate Receptor-LTD) is enhanced in the hippocampus of Ts1Cje mice and this is correlated with an increased proportion of a particular category of mushroom spines in hippocampal pyramidal neurons. Remarkably, prenatal treatment of these mice with rapamycin has a positive pharmacological effect on both phenotypes, supporting the therapeutic potential of rapamycin/rapalogs for DS intellectual disability.


Subject(s)
Dendritic Spines/metabolism , Dendritic Spines/pathology , Down Syndrome/pathology , Down Syndrome/physiopathology , Long-Term Synaptic Depression , Receptors, Metabotropic Glutamate/metabolism , Sirolimus/pharmacology , Animals , Dendritic Spines/drug effects , Disease Models, Animal , Fragile X Mental Retardation Protein/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Hippocampus/physiopathology , Long-Term Synaptic Depression/drug effects , Mice, Transgenic , Mitochondrial Proteins/metabolism , Neuronal Plasticity/drug effects , Proteomics , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Pyramidal Cells/pathology , Synapses/drug effects , Synapses/metabolism
3.
Mol Cell Neurosci ; 95: 79-85, 2019 03.
Article in English | MEDLINE | ID: mdl-30763690

ABSTRACT

Trisomy 21, also known as Down syndrome (DS), is the most frequent genetic cause of intellectual impairment. In mouse models of DS, deficits in hippocampal synaptic plasticity have been observed, in conjunction with alterations to local dendritic translation that are likely to influence plasticity, learning and memory. Here we show that expression of a local translational regulator, the Cytoplasmic Polyadenylation Element Binding Protein 1 (CPEB1), is enhanced in hippocampal neurons from the Ts1Cje DS mouse model. Interestingly, this protein, which is also involved in dendritic mRNA transport, is overexpressed in dendrites of neurons derived from DS human induced pluripotent stem cells (hIPSCs). Moreover, there is an increase in the mRNA levels of α-Calmodulin Kinase II (α-CaMKII) and Microtubule-associated protein 1B (MAP1B), two dendritic mRNAs, in Ts1Cje synaptoneurosomes. Taking into account the fundamental role of CPEB1 protein and its target mRNAs in synaptic plasticity, these data could be relevant to the intellectual impairment in the context of DS.


Subject(s)
Cyclic AMP Response Element-Binding Protein/metabolism , Down Syndrome/metabolism , Hippocampus/metabolism , Induced Pluripotent Stem Cells/metabolism , Neural Stem Cells/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Cells, Cultured , Cyclic AMP Response Element-Binding Protein/genetics , Dendrites/metabolism , Down Syndrome/pathology , Humans , Induced Pluripotent Stem Cells/cytology , Mice , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Neural Stem Cells/cytology
4.
Proteomics ; 18(14): e1800005, 2018 07.
Article in English | MEDLINE | ID: mdl-29923338

ABSTRACT

Several proteomic analyses have been performed on synaptic fractions isolated from cortex or even total brain, resulting in preparations with a high synaptic heterogeneity and complexity. Synaptoneurosomes (SNs) are subcellular membranous elements that contain sealed pre- and post-synaptic components. They are obtained by subcellular fractionation of brain homogenates and serve as a suitable model to study many aspects of the synapse physiology. Here the proteomic content of SNs isolated from hippocampus of adult mice, a brain region involved in memory that presents lower synaptic heterogeneity than cortex, is reported. Interestingly, in addition to pre- and post-synaptic proteins, proteins involved in RNA binding and translation are overrepresented in this preparation. These results validate the protocol previously reported for SNs isolation, and, as reported by other authors, highlight the relevance of local synaptic translation for hippocampal physiology.


Subject(s)
Dendrites/metabolism , Hippocampus/metabolism , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Protein Biosynthesis , Proteome/analysis , Synaptosomes/metabolism , Animals , Mice
5.
J Neurogenet ; 31(4): 223-230, 2017 12.
Article in English | MEDLINE | ID: mdl-29078722

ABSTRACT

Local translation of synaptic mRNAs is an important process related to key aspects of central nervous system development and physiology, including dendritogenesis, axonal growth cone morphology and guidance and synaptic plasticity. Accordingly, local translation is compromised in several intellectual disabilities, including Fragile X syndrome, tuberous sclerosis and Down syndrome. Down Syndrome Cell Adhesion Molecule (DSCAM) is a gene with ascribed functions in neuronal wiring that belongs to the Down Syndrome Critical Region (DSCR) of chromosome 21. In this review, we discuss the evidence for local translation of the DSCAM mRNA in dendrites and axonal growth cones of mouse hippocampal neurons, as well as the possible functions of the locally translated DSCAM protein.


Subject(s)
Cell Adhesion Molecules/metabolism , Dendrites/metabolism , Down Syndrome/metabolism , Hippocampus/metabolism , Neurons/metabolism , Animals , Growth Cones/metabolism , Humans , Mice , Protein Biosynthesis/physiology
6.
Neurobiol Dis ; 82: 516-525, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26388397

ABSTRACT

Down's syndrome (DS) is the most prevalent genetic intellectual disability. Memory deficits significantly contribute to the cognitive dysfunction in DS. Previously, we discovered that mTOR-dependent local translation, a pivotal process for some forms of synaptic plasticity, is deregulated in a DS mouse model. Here, we report that these mice exhibit deficits in both synaptic plasticity (i.e., BDNF-long term potentiation) and the persistence of spatial long-term memory. Interestingly, these deficits were fully reversible using rapamycin, a Food and Drug Administration-approved specific mTOR inhibitor; therefore, rapamycin may be a novel pharmacotherapy to improve cognition in DS.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Down Syndrome/drug therapy , Long-Term Potentiation/drug effects , Memory, Long-Term/drug effects , Nootropic Agents/pharmacology , Sirolimus/pharmacology , Animals , CA1 Region, Hippocampal/drug effects , CA1 Region, Hippocampal/physiopathology , Disease Models, Animal , Down Syndrome/physiopathology , Down Syndrome/psychology , Long-Term Potentiation/physiology , Male , Maze Learning/drug effects , Maze Learning/physiology , Memory Disorders/drug therapy , Memory, Long-Term/physiology , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Transgenic , Spatial Memory/drug effects , Spatial Memory/physiology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/metabolism , Tissue Culture Techniques
7.
Adv Neurobiol ; 8: 249-70, 2014.
Article in English | MEDLINE | ID: mdl-25300140

ABSTRACT

DSCAMs (Down syndrome cell adhesion molecules) are a group of immunoglobulin-like transmembrane proteins that contain fibronectin III domains. The founding member of the family was isolated in a positional cloning study that sought to identify genes located on chromosome 21 at the locus 21q22.2-q22.3 that is implicated in the neurological and cardiac phenotypes associated with Down's syndrome. In Drosophila, Dscam proteins are involved in neuronal wiring, while in vertebrates, the role of these cell adhesion molecules in neurogenesis, dendritogenesis, axonal outgrowth, synaptogenesis, and synaptic plasticity is only just beginning to be understood. In this chapter, we will review the functions ascribed to the two paralogous proteins found in humans, DSCAM and DSCAML1 (DSCAM-like 1), based on findings in knockout mice. The signaling pathways downstream of DSCAM activation and the role of DSCAM miss-expression in disease will be also discussed, particularly with regard to the intellectual disability in Down's syndrome.


Subject(s)
Cell Adhesion Molecules/metabolism , Central Nervous System/growth & development , Central Nervous System/metabolism , Animals , Cell Adhesion Molecules/genetics , Drosophila/genetics , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Humans , Models, Biological , Signal Transduction/physiology
9.
CNS Neurol Disord Drug Targets ; 13(1): 34-40, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24152334

ABSTRACT

An increasing amount of evidence suggests that the dysregulation of the Akt-mTOR (Akt-mammalian Target Of Rapamycin) signaling network is associated with intellectual disabilities, such as fragile X, tuberous sclerosis and Rett's syndrome. The Akt-mTOR pathway is involved in dendrite morphogenesis and synaptic plasticity, and it has been shown to modulate both glutamatergic and GABAergic synaptic transmission. We have recently shown that the AktmTOR pathway is hyperactive in the hippocampus of Ts1Cje mice, a model of Down's syndrome, leading to increased local dendritic translation that could interfere with synaptic plasticity. Rapamycin and rapalogs are specific inhibitors of mTOR, and some of these inhibitors are Food and Drug Administration-approved drugs. In this review, we discuss the molecular basis and consequences of Akt-mTOR hyperactivation in Down's syndrome, paying close attention to alterations in the molecular mechanisms underlying synaptic plasticity. We also analyze the pros and cons of using rapamycin/rapalogs for the treatment of the cognitive impairments associated with this condition.


Subject(s)
Cognition Disorders/drug therapy , Down Syndrome/metabolism , Immunosuppressive Agents/therapeutic use , Oncogene Protein v-akt/metabolism , Signal Transduction/physiology , Sirolimus/therapeutic use , TOR Serine-Threonine Kinases/metabolism , Animals , Cognition Disorders/etiology , Cognition Disorders/metabolism , Disease Models, Animal , Down Syndrome/complications , Down Syndrome/drug therapy , Down Syndrome/genetics , Humans , Mice , Signal Transduction/drug effects , Sirolimus/analogs & derivatives
10.
Prog Neurobiol ; 96(2): 268-82, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22285767

ABSTRACT

Local translation of dendritic mRNAs is a key aspect of dendrite and spine morphogenesis and synaptic plasticity, two phenomena generally compromised in intellectual disability disorders. Mammalian target of rapamycin (mTOR) is a protein kinase involved in a plethora of functions including dendritogenesis, plasticity and the regulation of local translation. Hence, this kinase may well be implicated in intellectual disability. Hyperactivation of mTOR has been recently reported in mouse models of Fragile X and tuberous sclerosis, two important causes of intellectual disability. Moreover, local dendritic translation seems to be increased in Fragile X syndrome. Recent findings show that the mTOR pathway is also deregulated in murine models of Rett's syndrome and Down's syndrome. As in Fragile X, local dendritic translation seems to be abnormally active in Down's syndrome mice, while rapamycin, a Food and Drug Administration-approved mTOR inhibitor, restores normal rates of translation. Rapamycin administration in tuberous sclerosis mice rescues deficits in behavior and synaptic plasticity. Indeed, mTOR-dependent deregulation of local translation may be a common trait in different intellectual deficiencies, suggesting that mTOR inhibitors may have significant therapeutic potential for the treatment of diverse forms of cognitive impairment.


Subject(s)
Intellectual Disability/genetics , Intellectual Disability/physiopathology , Protein Biosynthesis/physiology , TOR Serine-Threonine Kinases/metabolism , Animals , Dendrites/metabolism , Dendrites/ultrastructure , Down Syndrome/physiopathology , Fragile X Syndrome/physiopathology , Intellectual Disability/drug therapy , Neuronal Plasticity/physiology , RNA, Messenger/metabolism , Rett Syndrome/physiopathology , Sirolimus/therapeutic use , Synapses/physiology , Synapses/ultrastructure , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/genetics , Tuberous Sclerosis/physiopathology
11.
J Neurosci ; 31(26): 9445-55, 2011 Jun 29.
Article in English | MEDLINE | ID: mdl-21715609

ABSTRACT

As in other diseases associated with mental retardation, dendrite morphology and synaptic plasticity are impaired in Down's syndrome (DS). Both these features of neurons are critically influenced by BDNF, which regulates local dendritic translation through phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin (mTOR) and Ras-ERK signaling cascades. Here we show that the levels of BDNF and phosphorylated Akt-mTOR (but not Ras-ERK) pathway proteins are augmented in hippocampal dendrites of Ts1Cje mice, a DS model. Consequently, the rate of local dendritic translation is abnormally high and the modulatory effect of exogenous BDNF is lost. Interestingly, rapamycin (a Food and Drug Administration-approved drug) restores normal levels of phosphorylated Akt-mTOR proteins and normal rates of local translation in Ts1Cje neurons, opening new therapeutic perspectives for DS. The NMDAR inhibitors APV, MK-801, and memantine also restore the normal levels of phospho-mTOR in dendrites of Ts1Cje hippocampal neurons. We propose a model to explain how BDNF-mediated regulation of local translation is lost in the Ts1Cje hippocampus through the establishment of a glutamatergic positive-feedback loop. Together, these findings help elucidate the mechanisms underlying altered synaptic plasticity in DS.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Dendrites/metabolism , Down Syndrome/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/physiology , TOR Serine-Threonine Kinases/metabolism , Animals , Brain-Derived Neurotrophic Factor/genetics , Cells, Cultured , Dendrites/drug effects , Dendrites/genetics , Disease Models, Animal , Down Syndrome/genetics , Hippocampus/metabolism , Immunohistochemistry , Mice , Mice, Transgenic , Neurons/drug effects , Neurons/metabolism , Phosphorylation/drug effects , Phosphorylation/physiology , Protein Biosynthesis/drug effects , Protein Biosynthesis/physiology , Proto-Oncogene Proteins c-akt/genetics , Signal Transduction/drug effects , Sirolimus/pharmacology , Statistics, Nonparametric
12.
J Neurosci ; 30(40): 13537-48, 2010 Oct 06.
Article in English | MEDLINE | ID: mdl-20926679

ABSTRACT

Down's syndrome cell adhesion molecule (DSCAM) belongs to the Down's syndrome critical region of human chromosome 21, and it encodes a cell adhesion molecule involved in dendrite morphology and neuronal wiring. Although the function of DSCAM in the adult brain is unknown, its expression pattern suggests a role in synaptic plasticity. Local mRNA translation is a key process in axonal growth, dendritogenesis, and synaptogenesis during development, and in synaptic plasticity in adulthood. Here, we report the dendritic localization of DSCAM mRNA in the adult mouse hippocampus, where it associates with CPEB1 [cytoplasmic polyadenylation element (CPE) binding protein 1], an important regulator of mRNA transport and local translation. We identified five DSCAM isoforms produced by alternative polyadenylation bearing different combinations of regulatory CPE motifs. Overexpression of DSCAM in hippocampal neurons inhibited dendritic branching. Interestingly, dendritic levels of DSCAM mRNA and protein were increased in hippocampal neurons from Ts1Cje mice, a model of Down's syndrome. Most importantly, DSCAM dendritic translation was rapidly induced by NMDA in wild-type, but not in Ts1Cje neurons. We propose that impairment of the NMDA-mediated regulation of DSCAM translation may contribute to the alterations in dendritic morphology and/or synaptic plasticity in Down's syndrome.


Subject(s)
Cell Adhesion Molecules/genetics , Dendrites/metabolism , Down Syndrome/metabolism , Hippocampus/metabolism , N-Methylaspartate/physiology , Protein Biosynthesis/genetics , Animals , Animals, Newborn , Cell Adhesion Molecules/metabolism , Cells, Cultured , Dendrites/pathology , Disease Models, Animal , Down Syndrome/genetics , Down Syndrome/physiopathology , Female , Hippocampus/pathology , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Neuronal Plasticity/genetics , Xenopus laevis
13.
Mol Cell Neurosci ; 43(3): 308-14, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20035871

ABSTRACT

Changes in dendritic spine morphology, a hallmark of synaptic plasticity, involve remodeling of the actin cytoskeleton, a process that is regulated by Rho GTPases. RhoA, a member of this GTPase family, segregates to dendrites in differentiated neurons. Given the emerging role of dendritic mRNA local translation in synaptic plasticity, we have assessed the possible localization and translation of RhoA mRNA at dendrites. At this end, we have developed and describe here in detail an improved method for isolating hippocampal and neocortical mouse synaptoneurosomes. This synaptoneurosomal preparation is much more enriched in synaptic proteins than those obtained in former methods, exhibits bona fide electron microscopy pre- and postsynaptic morphologies, contains abundant dendritic mRNAs, and is competent for activity-regulated protein synthesis. Using this preparation, we have found that RhoA mRNA is dendritically localized and its local translation is enhanced by BDNF stimulation. These findings suggest that some of the known functions of RhoA on spine morphology may be mediated by regulating its local translation.


Subject(s)
Dendrites/metabolism , Neurons , Synaptosomes/chemistry , rhoA GTP-Binding Protein/metabolism , Animals , Brain-Derived Neurotrophic Factor/metabolism , Cytoskeleton/metabolism , Dendrites/ultrastructure , Hippocampus/cytology , Hippocampus/metabolism , Mice , Mice, Inbred C57BL , Neuronal Plasticity/physiology , Neurons/cytology , Neurons/metabolism , Protein Biosynthesis , Synaptosomes/metabolism , rhoA GTP-Binding Protein/genetics
14.
Mol Cell Neurosci ; 35(2): 230-6, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17399993

ABSTRACT

Engrailed1 (En1) is a homeoprotein transcription factor expressed throughout adulthood in several midbrain cells, including the dopaminergic neurons of the substantia nigra. Here we report the presence of Engrailed protein and En1 mRNA in proximal dendrites of these neurons and of En1 mRNA in ventral midbrain synaptoneurosomes. We show that the 3' untranslated region of En1 mRNA contains a functional cytoplasmic polyadenylation element (CPE), suggesting that its dendritic localization is regulated by CPE binding protein (CPEB). In order to evaluate activity-regulated translation, conditions were developed using primary midbrain neurons. With this in vitro model, En1 mRNA translation is increased by depolarization in a polyadenylation dependent manner. Furthermore, En1 translation is prevented by rapamycin, implicating the mTOR pathway, which is known to regulate dendritic translation. Together, these results suggest an activity-dependent role for Engrailed in midbrain dopaminergic neuron physiology.


Subject(s)
Dendrites/metabolism , Homeodomain Proteins/metabolism , Neurons/cytology , Animals , Cells, Cultured , Electrophoretic Mobility Shift Assay/methods , Embryo, Mammalian , Gene Expression/physiology , Homeodomain Proteins/genetics , In Situ Hybridization/methods , Mesencephalon/cytology , Mice , Protein Biosynthesis , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Synaptosomes/metabolism
15.
Mol Microbiol ; 57(6): 1582-92, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16135226

ABSTRACT

Anabaena sp. strain PCC 7120 is a filamentous cyanobacterium that can fix N2 in differentiated cells called heterocysts. The products of Anabaena open reading frames (ORFs) all1046, all1047, all1284, alr1834 and all2912 were identified as putative elements of a neutral amino acid permease. Anabaena mutants of these ORFs were strongly affected (1-12% of the wild-type activity) in the transport of Pro, Phe, Leu and Gly and also impaired (17-30% of the wild-type activity) in the transport of Ala and Ser. These results identified those ORFs as the nat genes encoding the N-I neutral amino acid permease. According to amino acid sequence homologies, natA (all1046) and natE (all2912) encode ATPases, natC (all1047) and natD (all1284) encode transmembrane proteins, and natB (alr1834) encodes a periplasmic substrate-binding protein of an ABC-type uptake transporter. The natA, natC, natD and natE mutants showed defects in Gln and His uptake that were not observed in the natB mutant suggesting that NatB is not a binding protein for Gln or His. The nat mutants released hydrophobic amino acids to the medium, and amino acid release took place at higher levels in cultures incubated in the absence of combined N than in the presence of nitrate. Alanine was the amino acid released at highest levels, and its release was impaired in a mutant unable to develop heterocysts. The nat mutants were also impaired in diazotrophic growth, with natA, natC, natD and natE mutants showing more severe defects than the natB mutant. Expression of natA and natC, which constitute an operon, natCA, as well as of natB was studied and found to take place in vegetative cells but not in the heterocysts. These results indicate that the N-I permease is necessary for normal growth of Anabaena sp. strain PCC 7120 on N2, and that this permease has a role in the diazotrophic filament specifically in the vegetative cells.


Subject(s)
ATP-Binding Cassette Transporters/metabolism , Amino Acid Transport Systems/metabolism , Anabaena/growth & development , Anabaena/genetics , Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , ATP-Binding Cassette Transporters/genetics , Amino Acid Transport Systems/genetics , Amino Acid Transport Systems, Neutral , Amino Acids, Neutral/metabolism , Anabaena/metabolism , Bacterial Proteins/genetics , Culture Media , Mutation
16.
Brain Res Brain Res Rev ; 49(2): 416-28, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16054223

ABSTRACT

In neurons, a network of endocytic proteins accomplishes highly regulated processes such as synaptic vesicle cycling and the timely internalization of intracellular signaling molecules. In this review, we discuss recent advances on molecular networks created through interactions between proteins bearing the Eps15 homology (EH) domain and partner proteins containing the Asn-Pro-Phe (NPF) motif, which participate in important aspects of neuronal function as the synaptic vesicle cycle, the internalization of nerve growth factor (NGF), the determination of neuronal cell fate, the development of synapses and the trafficking of postsynaptic receptors. We discuss novel functional findings on the role of intersectin and synaptojanin and then we focus on the features of an emerging family of EH domain proteins termed EHDs (EH domain proteins), which are important for endocytic recycling of membrane proteins.


Subject(s)
EF Hand Motifs/physiology , Neurons/cytology , Phosphoproteins/metabolism , Sequence Homology, Amino Acid , Synapses/metabolism , Amino Acid Sequence , Animals , Conservation of Natural Resources , Endocytosis/physiology , Humans , Models, Biological , Models, Molecular , Molecular Sequence Data , Phosphoproteins/chemistry , Phosphoproteins/genetics
17.
Development ; 130(9): 1867-76, 2003 May.
Article in English | MEDLINE | ID: mdl-12642491

ABSTRACT

The MAP1B (Mtap1b) promoter presents two evolutionary conserved overlapping homeoproteins and Hepatocyte nuclear factor 3beta (HNF3beta/Foxa2) cognate binding sites (defining putative homeoprotein/Fox sites, HF1 and HF2). Accordingly, the promoter domain containing HF1 and HF2 is recognized by cerebellum nuclear extracts containing Engrailed and Foxa2 and has regulatory functions in primary cultures of embryonic mesmetencephalic nerve cells. Transfection experiments further demonstrate that Engrailed and Foxa2 interact physiologically in a dose-dependent manner: Foxa2 antagonizes the Engrailed-driven regulation of the MAP1B promoter, and vice versa. This led us to investigate if Engrailed and Foxa2 interact directly. Direct interaction was confirmed by pull-down experiments, and the regions participating in this interaction were identified. In Foxa2 the interacting domain is the Forkhead box DNA-binding domain. In Engrailed, two independent interacting domains exist: the homeodomain and a region that includes the Pbx-binding domain. Finally, Foxa2 not only binds Engrailed but also Lim1, Gsc and Hoxa5 homeoproteins and in the four cases Foxa2 binds at least the homeodomain. Based on the involvement of conserved domains in both classes of proteins, it is proposed that the interaction between Forkhead box transcription factors and homeoproteins is a general phenomenon.


Subject(s)
DNA-Binding Proteins/metabolism , Homeodomain Proteins/metabolism , Microtubule-Associated Proteins/genetics , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Transcription Factors , Animals , Base Sequence , Binding Sites , Brain/embryology , Hepatocyte Nuclear Factor 3-beta , Mice , Microtubule-Associated Proteins/metabolism , Molecular Sequence Data , Nerve Tissue Proteins/metabolism , Neurons/metabolism
18.
Mol Microbiol ; 43(3): 703-15, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11929526

ABSTRACT

Urea is an important nitrogen source for many microorganisms, but urea active transporters have not been characterized at a molecular level in any bacterium. Cells of Synechocystis sp. PCC 6803 and Anabaena sp. PCC 7120 exhibited the capacity to take up [14C]-urea from low-concentration (<1 microM) urea solutions. The Ks of Anabaena cells for urea was about 0.11 microM, and the observed uptake activity involved the transport and metabolism of urea. In contrast to urease, which was constitutively ex-pressed, expression of the high-affinity urea uptake activity was subjected to nitrogen control. In an Anabaena ureG (urease-) mutant, a concentrative, active transport of urea could be demonstrated. We found that a mutant of open reading frame (ORF) sll0374 from the Synechocystis genomic sequence lacked urea transport activity. This ORF encoded a conserved component of an ABC-type transporter, but it is not clustered together with any other possible transporter-encoding gene. An Anabaena homologue of sll0374, urtE, was isolated and found to be part of a cluster of genes, urtABCDE, putatively encoding all the elements of an ABC-type permease. Although the longest transcript that we could detect only covered urtABC, the impairment of urea transport by inactivation of urtA, urtB or urtE suggested that the whole gene cluster is expressed producing the urea permease. Expression was induced under nitrogen-limiting conditions, and a complex promoter regulated by the cyanobacterial global nitrogen control transcription factor NtcA was found upstream from urtA. Our work adds urea to the known substrates of the versatile class of ABC-type transporters and suggests the involvement of a transporter of this superfamily in urea scavenging by some bacteria in natural environments.


Subject(s)
ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Anabaena/metabolism , Anabaena/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cloning, Molecular , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Bacterial , Molecular Sequence Data , Mutation , Phosphate-Binding Proteins , Promoter Regions, Genetic , Transcription Factors/genetics , Transcription Factors/metabolism , Urea/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...